Novel Molecules for Cancer Treatment (3rd Edition)
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Natural and Bio-derived Molecules".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 1768
Special Issue Editor
Interests: gastric cancer; pancreatic cancer; colorectal cancer; metastatic melanoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer can appear anywhere in the body due to the accumulation of mutations and other genomic aberrations that lead to uncontrolled cell proliferation, the inhibition of apoptosis, and increased cell migration. Tumor cells are able to activate via mechanisms that generate tumors and develop metastases through the induction of the epithelial-to-mesenchymal transition, angiogenesis, and an immunosuppressive microenvironment. Other crucial events in tumorigenesis are the emergence of the undifferentiated phenotype, in addition to the generation and maintenance of cancer stem cells. In carcinogenesis, the coactivation of several genes and pathways is common, and the study of these factors and signaling pathways has enabled the identification of novel targets for the design of drugs. These drugs could be chemically synthesized or isolated from natural substances and represent a signficant advancement in realizing personalized medicine in present clinical practice.
In this Special Issue, entitled "Novel Molecules for Cancer Treatment (3rd Edition)", we encourage authors to submit high-quality research articles that address novel biomolecules and provide the scientific and clinical communities with strong evidence of their antitumor activity. This activity could be observed in both solid tumors and in hematological malignancies, and could be evaluated with in vitro and/or in vivo models. On the other hand, we are open to receiving updated reviews concerning novel molecules or treatment strategies based on synthetic or natural compounds and that provide a basis for further translational oncological research.
I look forward to receiving your manuscripts.
Dr. Javier Martínez Useros
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- small molecules
- antibody-drug-conjugated
- tyrosine kinase inhibitors
- target therapy
- monoclonal antibodies
- immunotherapy
- natural compounds
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issues
- Novel Molecules for Cancer Treatment in Biomolecules (6 articles)
- Novel Molecules for Cancer Treatment (2nd Edition) in Biomolecules (6 articles)
